AGP Executive Report
Last update: 24 minutes agoEmergency Care Spotlight: Magen David Adom marked its 96th anniversary, celebrating patients, volunteers and responders behind Israel’s nationwide emergency and blood services. Gene Therapy Breakthrough: Israeli researchers report a world-first gene therapy approach for a rare inherited epilepsy, with an FDA submission expected soon. Healthcare Innovation Funding: The Colton Consortium for Autoimmunity announced a $15M, three-year investment to expand cross-institution autoimmune research across NYU, Yale and Tel Aviv University. Pharma Restructuring: Teva plans layoffs of 250 employees at its Ramat Hovav API plant as part of a global active-ingredients restructuring, while continuing key production in Israel. Autoimmune/Neuroscience Pipeline: Teva also closed its acquisition of Emalex Biosciences, strengthening its late-stage neuroscience pipeline. Public Health Research: A Ben-Gurion University study links losing visceral belly fat to lower long-term type 2 diabetes risk, even if weight returns. Mental Health Science: A new study ties trauma-related mental illness to differences in thalamus size, depending on diagnosis and childhood adversity. Regional Health Impact: Israeli strikes in southern Lebanon killed at least 12–13 people in renewed fighting, underscoring ongoing strain on medical services amid displacement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
